PROM1 and central nervous system cancer: With progression to anaplastic gliomas (WHO grade 3) and GBM (WHO grade 4), the percentage of CD133 over 10 % decrease to 15.0 % (3 of 20) and 11.5 % (7 of 61), which seems opposite to grade of gliomas.